Evidence map›Paper›PMID 24921942›Full record

ArticlePloS one2014

Inhibition of the polyamine system counteracts β-amyloid peptide-induced memory impairment in mice: involvement of extrasynaptic NMDA receptors.

Guilherme Monteiro Gomes, Gerusa Duarte Dalmolin, Julia Bär, Anna Karpova, Carlos Fernando Mello, Michael R Kreutz, Maribel Antonello Rubin

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
2.2field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 54 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Engineered spermidine-secretingFrontiers in neuroscience · 2025
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. TwoeLife · 2021
    Article
  12. Article
  13. Review
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 2 countries.

Guilherme Monteiro GomesBiochemistry and Molecular Biology Department, Natural and Exact Sciences Center, Federal University of Santa Maria, Santa Maria, RS, Brazil; Research Group Neuroplasticity, Leibniz Institute for Neurobiology, Magdeburg, Germany.
Gerusa Duarte DalmolinBiochemistry and Molecular Biology Department, Natural and Exact Sciences Center, Federal University of Santa Maria, Santa Maria, RS, Brazil.
Julia BärResearch Group Neuroplasticity, Leibniz Institute for Neurobiology, Magdeburg, Germany.
Anna KarpovaResearch Group Neuroplasticity, Leibniz Institute for Neurobiology, Magdeburg, Germany.
Carlos Fernando MelloPhysiology and Pharmacology Department, Federal University of Santa Maria, Santa Maria, RS, Brazil.
Michael R KreutzResearch Group Neuroplasticity, Leibniz Institute for Neurobiology, Magdeburg, Germany.
Maribel Antonello RubinBiochemistry and Molecular Biology Department, Natural and Exact Sciences Center, Federal University of Santa Maria, Santa Maria, RS, Brazil.
Universidade Federal de Santa Maria · BRLeibniz Institute for Neurobiology · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In Alzheimer's disease (AD), the β-amyloid peptide (Aβ) has been causally linked to synaptic dysfunction and cognitive impairment. Several studies have shown that N-Methyl-D-Aspartate receptors (NMDAR) activation is involved in the detrimental actions of Aβ. Polyamines, like spermidine and spermine, are positive modulators of NMDAR function and it has been shown that their levels are regulated by Aβ. In this study we show here that interruption of NMDAR modulation by polyamines through blockade of its binding site at NMDAR by arcaine (0.02 nmol/site), or inhibition of polyamine synthesis by DFMO (2.7 nmol/site), reverses Aβ25-35-induced memory impairment in mice in a novel object recognition task. Incubation of hippocampal cell cultures with Aβ25-35 (10 µM) significantly increased the nuclear accumulation of Jacob, which is a hallmark of NMDAR activation. The Aβ-induced nuclear translocation of Jacob was blocked upon application of traxoprodil (4 nM), arcaine (4 µM) or DFMO (5 µM), suggesting that activation of the polyamine binding site at NMDAR located probably at extrasynaptic sites might underlie the cognitive deficits of Aβ25-35-treated mice. Extrasynaptic NMDAR activation in primary neurons results in a stripping of synaptic contacts and simplification of neuronal cytoarchitecture. Aβ25-35 application in hippocampal primary cell cultures reduced dendritic spine density and induced alterations on spine morphology. Application of traxoprodil (4 nM), arcaine (4 µM) or DFMO (5 µM) reversed these effects of Aβ25-35. Taken together these data provide evidence that polyamine modulation of extrasynaptic NMDAR signaling might be involved in Aβ pathology.

Indexed as

Amyloid beta-PeptidesAnimalsBiguanidesBinding SitesCell NucleusDendritic SpinesExploratory BehaviorHippocampusMaleMemory DisordersMiceNerve Tissue ProteinsPeptide FragmentsPiperidinesPolyaminesReceptors, N-Methyl-D-AspartateAmyloid beta-Peptidesamyloid beta-protein (25-35)arcaineBiguanidesJacob protein, mouseNerve Tissue ProteinsPeptide FragmentsPiperidinesPolyaminesReceptors, N-Methyl-D-AspartateSpermidinetraxoprodil mesylate

Identifiers

PMID24921942
PMCPMC4055672
OpenAlexW2066828362

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.